Evidence map›Paper›PMID 31095603›Full record

ArticlePloS one2019

Does MHC heterozygosity influence microbiota form and function?

M A Wadud Khan, W Zac Stephens, Ahmed Dawood Mohammed, June Louise Round, Jason Lee Kubinak

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 36 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. HLA-CPediatric diabetes · 2025
    Article
  9. Article
  10. Article
  11. Article
  12. Host gene effects on gut microbiota in type 1 diabetes.Biochemical Society transactions · 2022
    Review
  13. Article
  14. Article
  15. Comparative Analysis ofVeterinary sciences · 2021
    Article
  16. Article
  17. Review
  18. Article
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

M A Wadud KhanDepartment of Biology, University of Texas at Arlington, Arlington, Texas, United States of America.
W Zac StephensDepartment of Pathology, University of Utah, Salt Lake City, Utah, United States of America.ORCID 0000-0002-8072-9023
Ahmed Dawood MohammedDepartment of Pathology, Microbiology, and Immunology, University of South Carolina School of Medicine, Columbia, South Carolina, United States of America.
June Louise RoundDepartment of Pathology, University of Utah, Salt Lake City, Utah, United States of America.
Jason Lee KubinakDepartment of Pathology, University of Utah, Salt Lake City, Utah, United States of America.ORCID 0000-0001-9866-8225
University of South Carolina · USUniversity of Utah · USThe University of Texas at Arlington · US

Funding

Training Program in Microbial PathogenesisT32AI055434 · NIAID · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI MULVEY, MATTHEW A, PLANELLES, VICENTE · 2004 to 2025
$6.0M
Developing therapies to target the microbiotaDP2AT008746 · NCCIH · UNIVERSITY OF UTAH · PI ROUND, JUNE LOUISE · 2014 to 2014
$2.2M
Exploring the function of a novel, microbiota-regulated gene in T cellsR21AI109122 · NIAID · UNIVERSITY OF UTAH · PI ROUND, JUNE LOUISE · 2014 to 2015
$410k
The role of T cell intrinsic TLR signaling on host-commensal interactionsR56AI107090 · NIAID · UNIVERSITY OF UTAH · PI ROUND, JUNE LOUISE · 2013 to 2013
$350k
Exploring the mechanisms of T cell intrinsic TLR2 signaling on Treg functionK22AI095375 · NIAID · UNIVERSITY OF UTAH · PI ROUND, JUNE LOUISE · 2012 to 2013
$270k
Exploring how B cell Maturation Pathways Influence Microbiota Composition and Host HealthK22AI123481 · NIAID · UNIVERSITY OF TEXAS ARLINGTON · PI KUBINAK, JASON L · 2017 to 2018
$263k
HIV VACCINE PRODUCTIONN01AI095375 · NIAID · SRI INTERNATIONAL · PI KUNG, ADA P · 1999 to 2000
$61k
NCCIH NIH HHS DP2 AT008746NIAID NIH HHS K22 AI095375NIAID NIH HHS K22 AI123481NIAID NIH HHS N01 AI095375NIAID NIH HHS R21 AI109122NIAID NIH HHS R56 AI107090NIAID NIH HHS T32 AI055434
6 · The paper itself

Abstract

MHC molecules are essential for the adaptive immune response, and they are the most polymorphic genetic loci in vertebrates. Extreme genetic variation at these loci is paradoxical given their central importance to host health. Classic models of MHC gene evolution center on antagonistic host-pathogen interactions to promote gene diversification and allelic diversity in host populations. However, all multicellular organisms are persistently colonized by their microbiota that perform essential metabolic functions for their host and protect from infection. Here, we provide data to support the hypothesis that MHC heterozygote advantage (a main force of selection thought to drive MHC gene evolution), may operate by enhancing fitness advantages conferred by the host's microbiome. We utilized fecal 16S rRNA gene sequences and their predicted metagenome datasets collected from multiple MHC congenic homozygote and heterozygote mouse strains to describe the influence of MHC heterozygosity on microbiome form and function. We find that in contrast to homozygosity at MHC loci, MHC heterozygosity promotes functional diversification of the microbiome, enhances microbial network connectivity, and results in enrichment for a variety of microbial functions that are positively associated with host fitness. We demonstrate that taxonomic and functional diversity of the microbiome is positively correlated in MHC heterozygote but not homozygote animals, suggesting that heterozygote microbiomes are more functionally adaptive under similar environmental conditions than homozygote microbiomes. Our data complement previous observations on the role of MHC polymorphism in sculpting microbiota composition, but also provide functional insights into how MHC heterozygosity may enhance host health by modulating microbiome form and function. We also provide evidence to support that MHC heterozygosity limits functional redundancy among commensal microbes and may enhance the metabolic versatility of their microbiome. Results from our analyses yield multiple testable predictions regarding the role of MHC heterozygosity on the microbiome that will help guide future research in the area of MHC-microbiome interactions.

Indexed as

HeterozygoteAnimalsFecesFemaleGenetic VariationGenotypeHomozygoteMajor Histocompatibility ComplexMiceMicrobiota

Identifiers

PMID31095603
PMCPMC6522005
OpenAlexW2944905271

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.